baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Soc. Generale Knock-Out AMGN/ DE000SW52PT0 /

09/09/2024 08:33:20	Chg.-0.06	Bid10:44:48	Ask10:44:48	Underlying	Strike price	Expiration date	Option type
4.58EUR	-1.29%	4.60 Bid Size: 1,000	4.78 Ask Size: 1,000	Amgen Inc	271.933 USD	31/12/2078	Call

GlobeNewswire 29/08 Great Place To Work Announces the 2024 Best Workplaces in Asia Representing 6.9 Million Employee Exp...

GlobeNewswire 28/08 Prevent Cancer Annual Gala to celebrate three decades of commitment to cancer prevention and early d...

GlobeNewswire 26/08 Molecular Partners Reports H1 2024 Corporate Highlights and Financials

GlobeNewswire 26/08 Eliem Therapeutics Announces Additions to its Leadership Team

GlobeNewswire 15/08 Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...

GlobeNewswire 12/08 TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 08/08 CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 08/08 Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer

TeleTrader 07/08 US closes lower with earnings in focus

TeleTrader 07/08 US turns red, Dow loses more than 200 pts

GlobeNewswire 07/08 89bio Appoints Francis Sarena as Chief Operating Officer

TeleTrader 06/08 Amgen books revenue of $8.4B in Q2, up 20%

TeleTrader 06/08 US extends premarket gains, Dow surges 250 pts

GlobeNewswire 05/08 Avalyn Appoints Erin Lavelle, Seasoned Biopharma Finance Executive, to its Board of Directors

TeleTrader 01/08 Dow jumps 250 pts as Meta surges more than 10%

GlobeNewswire 01/08 CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024

GlobeNewswire 22/07 Oxford BioTherapeutics Named Best Tech SME of the Year at Thames Valley Tech & Innovation Awards 202...

GlobeNewswire 09/07 ImCheck Appoints Stephan Braun as Chief Medical Officer

GlobeNewswire 02/07 Alvotech Announces Positive Topline Results from Confirmatory Patient Study for AVT03, a Proposed Bi...

GlobeNewswire 01/07 Zenas BioPharma Appoints Orlando Oliveira as Chief Commercial Officer

GlobeNewswire 27/06 Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 M...

GlobeNewswire 27/06 Coherus BioSciences Announces Divestiture of YUSIMRY (adalimumab-aqvh) in a $40 Million Upfront All ...

GlobeNewswire 26/06 COUR Pharmaceuticals Appoints Tim Walbert to its Board of Directors

GlobeNewswire 26/06 Compass Pathways appoints Lori Englebert as Chief Commercial Officer

GlobeNewswire 25/06 Arthritis Foundation Launches Carolina Hills Classic Bike Tour, Coming June 2025

Soc. Generale Knock-Out AMGN/ DE000SW52PT0 /

If you wish to receive reply to your feedback, please provide your email address.